MiR-145 expression and rare NOTCH1 variants in bicuspid aortic valve-associated aortopathy

Standard

MiR-145 expression and rare NOTCH1 variants in bicuspid aortic valve-associated aortopathy. / Girdauskas, Evaldas; Petersen, Johannes; Neumann, Niklas; Ungelenk, Martin; Kurth, Ingo; Reichenspurner, Hermann; Zeller, Tanja.

in: PLOS ONE, Jahrgang 13, Nr. 7, 2018, S. e0200205.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{8ac15f19ca8e4493bb382f7fb6f12ccf,
title = "MiR-145 expression and rare NOTCH1 variants in bicuspid aortic valve-associated aortopathy",
abstract = "MicroRNAs (miRNAs) may serve as elegant tool to improve risk stratification in bicuspid aortic valve (BAV)-associated aortopathy. However, the exact pathogenetic pathway by which miRNAs impact aortopathy progression is unknown. Herewith, we aimed to analyze the association between circulating miRNAs and rare variants of aortopathy-related genes. 63 BAV patients (mean age 47.3±11.3 years, 92% male) with a root dilatation phenotype, who underwent aortic valve+/-proximal aortic surgery at a single institution (mean post-AVR follow-up 10.3±6.9 years) were analyzed. A custom-made HaloPlex HS panel including 20 aortopathy-related genes was used for the genetic testing. miRNAs were extracted from whole blood and miRNA analysis was performed using miRNA-specific assay. Study endpoint was the association between circulating miRNAs and rare genetic variants in the aortopathy gene panel. The study cohort was divided into a subgroup with rare variants vs. a subgroup without rare variants based on the presence of rare variants in the respective genes (i.e., at least one variant present). The genetic analysis yielded n = 6 potentially and likely pathogenic rare variants within the NOTCH1 gene as being the most common finding. Univariate analysis between blood miRNAs and NOTCH1 variants revealed a significantly lower expression of miR-145 in the subgroup of patients with NOTCH1 variants vs. those without NOTCH1 variants (i.e., delta Ct 4.95±0.74 vs. delta Ct 5.57±0.78, p = 0.04). Our preliminary data demonstrate a significant association between blood miR-145 expression and the presence of rare NOTCH1 variants. This association may be indicative of a specific pathogenetic pathway in the development of genetically-triggered bicuspid aortopathy.",
keywords = "Aortic Valve/abnormalities, Bicuspid Aortic Valve Disease, Biomarkers/blood, Cross-Sectional Studies, Female, Follow-Up Studies, Gene Expression, Genetic Association Studies, Genetic Predisposition to Disease, Genetic Variation, Heart Valve Diseases/blood, Humans, Male, MicroRNAs/blood, Middle Aged, Preliminary Data, Receptor, Notch1/genetics",
author = "Evaldas Girdauskas and Johannes Petersen and Niklas Neumann and Martin Ungelenk and Ingo Kurth and Hermann Reichenspurner and Tanja Zeller",
year = "2018",
doi = "10.1371/journal.pone.0200205",
language = "English",
volume = "13",
pages = "e0200205",
journal = "PLOS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

RIS

TY - JOUR

T1 - MiR-145 expression and rare NOTCH1 variants in bicuspid aortic valve-associated aortopathy

AU - Girdauskas, Evaldas

AU - Petersen, Johannes

AU - Neumann, Niklas

AU - Ungelenk, Martin

AU - Kurth, Ingo

AU - Reichenspurner, Hermann

AU - Zeller, Tanja

PY - 2018

Y1 - 2018

N2 - MicroRNAs (miRNAs) may serve as elegant tool to improve risk stratification in bicuspid aortic valve (BAV)-associated aortopathy. However, the exact pathogenetic pathway by which miRNAs impact aortopathy progression is unknown. Herewith, we aimed to analyze the association between circulating miRNAs and rare variants of aortopathy-related genes. 63 BAV patients (mean age 47.3±11.3 years, 92% male) with a root dilatation phenotype, who underwent aortic valve+/-proximal aortic surgery at a single institution (mean post-AVR follow-up 10.3±6.9 years) were analyzed. A custom-made HaloPlex HS panel including 20 aortopathy-related genes was used for the genetic testing. miRNAs were extracted from whole blood and miRNA analysis was performed using miRNA-specific assay. Study endpoint was the association between circulating miRNAs and rare genetic variants in the aortopathy gene panel. The study cohort was divided into a subgroup with rare variants vs. a subgroup without rare variants based on the presence of rare variants in the respective genes (i.e., at least one variant present). The genetic analysis yielded n = 6 potentially and likely pathogenic rare variants within the NOTCH1 gene as being the most common finding. Univariate analysis between blood miRNAs and NOTCH1 variants revealed a significantly lower expression of miR-145 in the subgroup of patients with NOTCH1 variants vs. those without NOTCH1 variants (i.e., delta Ct 4.95±0.74 vs. delta Ct 5.57±0.78, p = 0.04). Our preliminary data demonstrate a significant association between blood miR-145 expression and the presence of rare NOTCH1 variants. This association may be indicative of a specific pathogenetic pathway in the development of genetically-triggered bicuspid aortopathy.

AB - MicroRNAs (miRNAs) may serve as elegant tool to improve risk stratification in bicuspid aortic valve (BAV)-associated aortopathy. However, the exact pathogenetic pathway by which miRNAs impact aortopathy progression is unknown. Herewith, we aimed to analyze the association between circulating miRNAs and rare variants of aortopathy-related genes. 63 BAV patients (mean age 47.3±11.3 years, 92% male) with a root dilatation phenotype, who underwent aortic valve+/-proximal aortic surgery at a single institution (mean post-AVR follow-up 10.3±6.9 years) were analyzed. A custom-made HaloPlex HS panel including 20 aortopathy-related genes was used for the genetic testing. miRNAs were extracted from whole blood and miRNA analysis was performed using miRNA-specific assay. Study endpoint was the association between circulating miRNAs and rare genetic variants in the aortopathy gene panel. The study cohort was divided into a subgroup with rare variants vs. a subgroup without rare variants based on the presence of rare variants in the respective genes (i.e., at least one variant present). The genetic analysis yielded n = 6 potentially and likely pathogenic rare variants within the NOTCH1 gene as being the most common finding. Univariate analysis between blood miRNAs and NOTCH1 variants revealed a significantly lower expression of miR-145 in the subgroup of patients with NOTCH1 variants vs. those without NOTCH1 variants (i.e., delta Ct 4.95±0.74 vs. delta Ct 5.57±0.78, p = 0.04). Our preliminary data demonstrate a significant association between blood miR-145 expression and the presence of rare NOTCH1 variants. This association may be indicative of a specific pathogenetic pathway in the development of genetically-triggered bicuspid aortopathy.

KW - Aortic Valve/abnormalities

KW - Bicuspid Aortic Valve Disease

KW - Biomarkers/blood

KW - Cross-Sectional Studies

KW - Female

KW - Follow-Up Studies

KW - Gene Expression

KW - Genetic Association Studies

KW - Genetic Predisposition to Disease

KW - Genetic Variation

KW - Heart Valve Diseases/blood

KW - Humans

KW - Male

KW - MicroRNAs/blood

KW - Middle Aged

KW - Preliminary Data

KW - Receptor, Notch1/genetics

U2 - 10.1371/journal.pone.0200205

DO - 10.1371/journal.pone.0200205

M3 - SCORING: Journal article

C2 - 30059548

VL - 13

SP - e0200205

JO - PLOS ONE

JF - PLOS ONE

SN - 1932-6203

IS - 7

ER -